Podcast thumbnail for Navigating CIDP – Expert and Patient Perspectives

Navigating CIDP – Expert and Patient Perspectives

Claim This Podcast

by Medthority

6 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇩🇪

Podcast Overview

<p><span class="fabric-text-color-mark">Join Mark Stettner (University of Duisburg-Essen, Germany) as he discusses clinical insights on chronic inflammatory demyelinating polyneuropathy (CIDP) with healthcare professionals and a patient.</span><span> </span></p>

Language

🇺🇲

Publishing Since

3/9/2026

Reach the team behind Navigating CIDP – Expert and Patient Perspectives

Verified contact details for this show aren't on file yet — sign up to get notified when they land.

Recent Episodes

Episode thumbnail for Understanding and managing refractory CIDP

June 17, 2026

Understanding and managing refractory CIDP

Episode 6. Mark Stettner and Karissa Gable discuss the real-world challenges of managing refractory CIDP, from defining meaningful treatment response to recognizing when stability is no longer sufficient. Drawing on recent clinical trial findings and evolving insights into CIDP pathophysiology, they explore decision-making beyond first-line therapies and what current evidence can – and cannot – tell us about long-term care.

Episode thumbnail for Living with CIDP: Patient perspectives and clinical insights

April 22, 2026

Living with CIDP: Patient perspectives and clinical insights

Episode 5. Mark Stettner is once again joined by Claudia Sommer to discuss patients’ experiences of CIDP from diagnosis through long-term management, reflecting on the questions, uncertainties, and emotional challenges they commonly face. Drawing on clinical experience and patient-reported insights, they consider how clear, individualized communication, careful expectation-setting, and shared decision-making help clinicians support informed, confident patients over time.

Episode thumbnail for Nodopathies and paranodopathies: Clinical distinctions beyond CIDP

April 22, 2026

Nodopathies and paranodopathies: Clinical distinctions beyond CIDP

Episode 4. Claudia Sommer joins Mark Stettner to discuss how nodal and paranodal antibodies have reshaped our understanding of CIDP, from early discoveries in neurofascin, contactin, and CASPR1 antibodies to their recognition as distinct disease entities. The conversation also explores how antibody isotype, titer, and testing methodology influence diagnosis, prognosis, and therapeutic decision-making, offering practical insights for clinicians reassessing “atypical” CIDP cases.

6 total episodes available

Similar Podcasts

Discover related shows you might enjoy

Deep-dive analytics for Navigating CIDP – Expert and Patient Perspectives

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Navigating CIDP – Expert and Patient Perspectives?
<p><span class="fabric-text-color-mark">Join Mark Stettner (University of Duisburg-Essen, Germany) as he discusses clinical insights on chronic inflammatory demyelinating polyneuropathy (CIDP) with healthcare professionals and a patient.</span><span> </span></p>
How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.